Stocks and Investing
Stocks and Investing
Tue, August 16, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, August 15, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (VOR) at Strong Buy with Decreased Target to $20 on, Aug 15th, 2022
Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Vor Biopharma Inc." (VOR) at Strong Buy with Decreased Target from $26 to $20 on, Aug 15th, 2022.
Swayampakula has made no other calls on VOR in the last 4 months.
There are 3 other peers that have a rating on VOR. Out of the 3 peers that are also analyzing VOR, 1 agrees with Swayampakula's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrea Tan of "Goldman Sachs" Maintained at Hold with Decreased Target to $4 on, Tuesday, May 24th, 2022
These are the ratings of the 2 analyists that currently disagree with Swayampakula
- David Nierengarten of "Wedbush" Initiated at Buy and Held Target at $18 on, Tuesday, July 26th, 2022
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $15 on, Friday, May 13th, 2022
Contributing Sources